Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis.

We described the IS use (first and second-line) for children with AD in a French retrospective national cohort, by using two survival analyses: 'drug survival' (DS, defined as the duration of treatment) and 'post-drug survival' (PDS, defined as the time between the end of first-line and the beginning of second-line). PMID: 32037515 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32037515?dopt=Abstract

Source: The British Journal of Dermatology - February 8, 2020 Category: Dermatology Authors: Chambrelan E, Barbarot S, Bekel L, Poizeau F, Mahé E, Puzenat E, Delaunay J, Mallet S, Bessis D, Maruani A, Miquel J, Raison-Peyron N, Abasq C, Phan A, Du Thanh A, Kupfer I, Bonniaud B, Bouzille G, Dupuy A, Droitcourt C, Groupe de Recherche sur l’Eczé Tags: Br J Dermatol Source Type: research